Episode Details

Back to Episodes

The drug behind Europe's most valuable company

Episode 2 Published 2 years, 6 months ago
Description

How much harm has been done by decades of governments investing too little? Is buy-now-pay-later causing misery or joy for young shoppers? Are supermarkets cutting prices fast enough? Is Novo Nordisk’s anti obesity wonder drug Semaglutide the most important pharmaceutical discovery of the century?


Join Robert and Steph as they answer all these questions and more on today's episode of The Rest Is Money.

Learn more about your ad choices. Visit podcastchoices.com/adchoices

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us